HOUSTON, Texas – Plunkett Research, Ltd. recently announced an important market research and competitive analysis report, Plunkett’s Biotechnology, Drugs & Genetics Industry Almanac, 2018 edition. A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms.
Biotechnology can be defined as the use of living organisms (such as bacteria), biological processes, or biological systems in order to create a desired end result or end product. Primary markets for biotechnology include: 1) Agriculture, where genetically-modified seeds are now in wide use in many nations. 2) The manufacture of enzymes for food processing or converting organic matter into ethanol for fuel. 3) Pharmaceuticals, where biotechnology creates such therapies as antibodies, interleukins and vaccines based on living organisms to target specific cellular conditions.
Plunkett Research lists top 400 companies in the Biotechnology, Drugs & Genetics Industry and names the top trends changing for the mid term.
Printed Almanac: ISBN 978-1-62831-450-2 (Available Now)
E-book: ISBN 978-1-62831-790-9 (Available Now)
Key Features Include:
Industry trends analysis, market data and competitive intelligence
Market forecasts and Industry Statistics
Industry Associations and Professional Societies List
In-Depth Profiles of hundreds of leading companies
Buyer may register for free access to search and export data at Plunkett Research Online
Link to 5-minute video overview of this industry
Statistical Tables Provided: 16
Companies Profiled: 381
Geographic Focus: Global
Key Questions Answered Include:
How is the industry evolving?
How is the industry being shaped by new technologies?
How is demand growing in emerging markets and mature economies?
What is the size of the market now and in the future?
What are the financial results of the leading companies?
What are the names and titles of top executives?
What are the top companies and what are their revenues?
This feature-rich book covers competitive intelligence, market research and business analysis—everything you need to know about the biotechnology, drugs & genetics business including:
The State of the Biotechnology Industry Today
Major Drug Companies Acquire or Partner With Smaller Biotech Firms
From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech
Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
Vaccines and Viruses in Drug Delivery
New Blockbuster Drugs Come to Market/ Drug Prices Soar
Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
Coupons and Other Marketing Schemes Obscure the Retail Prices of Drugs in the U.S.,
Which Are Vastly Higher than Prices Paid in Other Nations
Biotech and Orphan Drugs Create New Revenues for Drug Firms
Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
Stem Cells—Multiple Sources Stem from New Technologies
Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
Cloning of Farm Animals/Meat and Cheese Substitutes Created in Laboratories/3-D Printed Food Appears
Immunotherapy Promises New Approach to Fighting Cancers
Biotech & Genetics Industry Statistics
Biotech Industry Statistics and Market Size Overview
The U.S. Drug Discovery & Approval Process
U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2016
U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals: 1993-2016
Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2016
Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.: Fiscal Years 2015-2017
U.S. Exports & Imports of Pharmaceutical Products: 2011-1st Quarter 2017
U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution: 2009-2025
Prescription Drug Expenditures, U.S.: Selected Years, 1965-2025
Total U.S. Biotechnology Patents Granted per Year by Patent Class: 1977-2015
Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years 2016-2018
Global Area of Biotech Crops by Country: 2016
Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies: 1980-2015
Sales By Geographic Area, PhRMA Member Companies: 2014
Domestic U.S. Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies: 1980-2015
Domestic U.S. Biopharmaceutical R&D & R&D Abroad Breakdown, PhRMA Member Companies: 2014
Companies Mentioned Include:
Abeona Therapeutics Inc
Agilent Technologies Inc
Albany Molecular Research Inc